REGINA meets stage 1 endpoint in rectal cancer and moves to stage 2 with reduced dose regorafenib Presented ByDr Francesco Sclafani, Institut Jules Bordet, Belgium TrialPhase 2, REGINA ConferenceESMO GI 2024 TypePeer-reviewed article 21 August 2024 11:34